Sree Rayalaseema Hi-Strength Hypo profit and loss

Latest FY26
Revenue
₹667cr+4.6% on FY25
EBITDA
₹88.5cr−3.9% on FY25
Net profit
₹90.1cr+3.1% on FY25
EPS
₹53.24+4.5% on FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
6986676388661,650
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
54.354.839.522.134.1
7527226778881,684
Expenses
361332346396573
0.00.07.995.7654
−3.71.73.074.3−22.2
43.040.934.435.138.8
1.81.72.04.02.0
7.27.27.310.619.3
207204154155229
6165875557701,494
90.488.592.0111178
83.281.284.7100.0158
Profit
136134122118190
−12.2−13.5−3.1−10.90.0
123121119107190
30.629.729.027.936.3
0.91.02.70.4−0.1
31.530.731.728.336.2
91.890.187.579.0154
91.990.287.579.0154
−0.1−0.00.00.00.0
−3.9−33.433.0−23.132.4
87.956.712055.9187
Per share
₹54.09₹53.24₹50.96₹46.01₹89.87
₹54.09₹53.24₹50.96₹46.01₹89.87
Continuing & discontinued operations
−0.1−0.10.00.00.0
−0.0−0.00.00.00.0
Other comprehensive income — detail
−3.9−33.433.0——
−5.2−44.744.0−30.843.3
−1.3−11.211.0——
———−7.710.9
Per share — as-filed variants
₹54.13₹53.27₹50.96₹46.01₹89.87
₹54.13₹53.27₹50.96₹46.01₹89.87
−₹0.04−₹0.03₹0.00₹0.00₹0.00
−₹0.04−₹0.03₹0.00₹0.00₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
340333281300446
48.8%50.0%44.0%34.7%27.0%
Adjusted (ex-exceptional items) — derived
136134122118190
−12.2−13.5−3.1−10.90.0
10110089.787.0154
₹59.46₹59.19₹52.27₹50.67₹89.87
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SRHHYPOLTD₹499.15

Sree Rayalaseema Hi-Strength Hypo Limited

· Chemicals
AnnualQuarterly₹ CrorePeersGEMAROMADMCCSUDARCOLORJAYAGROGNKRONOXAMNPLSTCHEMFABPRIMOMcap ₹857 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,650.1866.0637.8667.0697.6
Other Income34.122.139.554.854.3
Total Income1,684.2888.2677.3721.7751.9
Expenses
+ Cost of Materials Consumed572.5395.6346.2331.8361.1
+ Purchases of Stock-in-Trade653.895.77.90.00.0
+ Changes in Inventories-22.274.33.01.7-3.7
+ Employee Benefit Expense38.835.134.440.943.0
+ Finance Costs2.04.02.01.71.8
+ Depreciation & Amortisation19.310.67.37.27.2
+ Other Expenses229.5154.7154.4204.1206.8
Total Expenses1,493.8770.0555.1587.4616.2
EBITDA177.7110.692.088.590.4
EBIT158.3100.084.781.283.2
Profit
PBT before Exceptional Items190.4118.1122.2134.3135.7
+ Exceptional Items0.0-10.9-3.1-13.5-12.2
Pretax Income190.4107.3119.2120.8123.4
+ Current Tax36.327.929.029.730.6
+ Deferred Tax-0.10.42.71.00.9
Tax Expense36.228.331.730.731.5
Net Income154.379.087.590.191.8
+ Net Income — Continuing Ops154.379.087.590.291.9
+ Net Income — Discontinued Ops0.00.00.0-0.0-0.1
+ Other Comprehensive Income32.4-23.133.0-33.4-3.9
Total Comprehensive Income186.755.9120.556.787.9
Per Share
Basic EPS89.8746.0150.9653.2454.09
Diluted EPS89.8746.0150.9653.2454.09
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax0.00.00.0-0.1-0.1
+ Tax — Discontinued Operations0.00.00.0-0.0-0.0
Other Comprehensive Income — detail
+ Other Comprehensive Income——33.0-33.4-3.9
+ Items NOT to be Reclassified to P&L43.3-30.844.0-44.7-5.2
+ Tax on Items NOT to be Reclassified——11.0-11.2-1.3
+ Tax on Items NOT to be Reclassified — alt tag10.9-7.7———
Per Share — as-filed variants
Basic EPS — Continuing Operations89.8746.0150.9653.2754.13
Diluted EPS — Continuing Operations89.8746.0150.9653.2754.13
Basic EPS — Discontinued Operations0.000.000.00-0.03-0.04
Diluted EPS — Discontinued Operations0.000.000.00-0.03-0.04
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit446.0300.4280.8333.5340.2
Gross Margin %27.0334.6944.0250.0048.77
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)190.4118.1122.2134.3135.7
− Exceptional Items (reconciliation)0.0-10.9-3.1-13.5-12.2
Net Income Adj (tax-effected)154.387.089.7100.2100.9
EPS Adj89.8750.6752.2759.1959.46
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.0010.00
Paid Up Equity Capital17.217.217.217.217.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.